Get the Weekly Intelligence Brief — top committee picks every Sunday.
ITGR · NYSE · STOCK

Integer Holdings (ITGR) Stock Analysis

Healthcare Updated September 06, 2026
$126.42
52W $62.00 – $126.80
69/100
$4.30B
34.3
0.61
AI Committee Verdict
Buy
69/100
Conviction: Contested · 80% agreement · 5 analysts
+0.8%
-17.0%
0.05:1
Contested
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.

Is ITGR Bullish or Bearish?

Bullish. Innellis AI committee rates Integer Holdings Corporation (ITGR) Buy with a composite score of 69/100 , based on 5 analysts with 80% agreement. Last updated September 06, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +6.13 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -13.87 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull & Bear Case

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • News sentiment is positive (+0.25 across 4 articles, 14d) — News
Bear Case
  • RSI at 84 is in overbought territory — Technical
  • MACD histogram negative -- bearish momentum — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
  • Weekly RSI at 93 -- overbought on the larger timeframe too — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of September 06, 2026
Overall Committee Score
69/100
Agreement
80%
Analysts
5
Conviction
Contested
Sector Rank
Top 7%
of 192 Healthcare peers
Growth Analyst bullish
85 / 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst neutral
44 / 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− RSI at 84 is in overbought territory
Risk Analyst bullish
70 / 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst bullish
80 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst bullish
66 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.25 across 4 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2704.43)
Open Full Terminal →

Investment Thesis Evolution

Committee score strengthened from 62.8 to 68.9.

Analyst-level changes:
  • Growth Analyst: score 70->85 (+15).
  • Value Analyst abstained (was neutral at 48).

Comparing 2026-09-05 to 2026-09-06 (1 day apart).

Technical Analysis

RSI (14)
83.5
Overbought
MACD Histogram
-1.009
Bearish Momentum
Trend Direction
Uptrend
Weekly: Downtrend
Market Structure
Hh Hl
Support
$104.97
Resistance
$127.39
Bollinger %B
1.42
Above Upper Band
Price vs Moving Averages
EMA 9
$125.46 Above
EMA 21
$122.93 Above
EMA 50
$114.07 Above
EMA 200
$99.71 Above

Fundamental Analysis

Valuation
69
Growth
65
Profitability
26
Financial Health
93
Cash Flow
70
Valuation
P/E Ratio 34.3×
P/B Ratio 2.50×
PEG Ratio 0.65
Dividend Yield 0.00%
52W High $126.80
52W Low $62.00
Quality & Growth
ROE 588.3%
ROA 301.3%
Gross Margin 2373.1%
Operating Margin 947.2%
Revenue Growth YoY
Debt / Equity 0.79
AI Fundamental Assessment
P/E ratio of 34.3 (rich relative to a 15-40x range); Price-to-book of 2.5x; PEG ratio of 0.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 5.9%; Return on assets of 3.0%; Net margin of 7.0%; Gross margin of 23.7%; Current ratio of 3.73 (healthy short-term liquidity); Debt-to-equity of 0.79; Free cash flow per share is positive (3.29); Most recent quarter beat estimates by 10.9%; EPS growth accelerating (-31.8% -> +33.3% QoQ); Analyst estimates falling over recent quarters
Get the Full ITGR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime